Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
Instead of reserving GLP-1 receptor agonists for later stages, emerging evidence suggests starting sooner may improve outcomes and Read More Managing Rapid Improvement on GLP-1 Therapy: When to Adjust the Rest of the Regimen May 6, 2026 Articles, Blood Glucose Control, Blood Glucose Control, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,535 views Rapid glycemic improvement with GLP-1 therapy is one of the most powerful benefits of modern diabetes care, but it can also create new clinical challenges
Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
GLP-1 injections make it easier to adopt these habits by reducing cravings and improving energy levels, but the effort still matters
Although GLP-1RAs are widely utilized for glycemic control and weight management in T2DM, gastrointestinal adverse events remain a significant barrier to patient adherence
For patients with pre-existing joint conditions, it is advisable to maintain regular contact with their rheumatologist or orthopaedic specialist throughout the course of treatment
